Multiple Sclerosis is an incurable disease which lacks a complete medication or a specific drug to the patient. âMedications used in MS are called Disease-Modifying Treatments (DMTs) since they do not stop the disease but only delay its activity and progression. DMTs have limited clinical efficacy and may have significant adverse effects. At present, we do not know what causes MS and, therefore, we cannot develop the MS cureâ Balashov KE., Multiple Sclerosis: New Hypotheses Are Needed.
Most of the multiple sclerosis medications are targeted on the reduction of relapses rather than the complete cure for associated symptoms. The first ever approved drug for this chronic acute demyelinating disease is interferon beta-1b in 1993. Most of these medications have unfavorable side effects that affect the patients. Journal of Multiple Sclerosis considers drug medications and related complications as one of the major issue of the journal. The journal is looking forward to present more articles based on this thus making the readers aware about the reliable medications.
Last date updated on September, 2020